Centene Corporation posted third quarter 2026 adjusted diluted earnings per share of $0.58, up from $0.50 in the same period last year, and raised its full-year 2026 adjusted diluted EPS guidance floor by $0.40 to greater than $5.20. The company also improved its full-year health benefits ratio (HBR) midpoint expectation by 15 basis points to 90.75%, tightening the guidance range to 90.4% to 91.1%. Total revenues for the quarter were $50.6 billion.
The headline figures arrive against a backdrop of significant organizational change. Centene began offering voluntary buyouts to its 61,000-strong workforce in June 2026 after ACA marketplace enrollment fell by roughly two million members following the expiration of enhanced premium tax credits at the start of the year. By September 30, its headcount had fallen to 53,900. The Q3 earnings release included $276 million in severance costs plus $35 million in enterprise optimization vendor costs.
Centene’s marketplace membership stood at 3.4 million at September 30, down from 5.8 million a year earlier, a decline of approximately 2.4 million members. Commercial revenue fell 21% year-over-year to $8.7 billion. The members who left were disproportionately those who had enrolled because of the subsidy: price-sensitive, often healthier, drawn to the exchanges primarily by the reduced premium cost. Their departure left a smaller but higher-acuity book.
The commercial HBR improved to 89.0% in Q3 2026 from 89.9% a year earlier. Centene attributed the improvement to better pricing and risk transfer reflecting the acuity of the remaining membership, though the prior-year quarter was also supported by a premium deficiency reserve reduction that had no equivalent in 2026. The same pattern drove the guidance upgrade: a smaller marketplace business with improved margins is worth more to the bottom line than a larger one with compressed margins on subsidized members.
The industry-wide context adds weight to this shift. The Centers for Medicare & Medicaid Services (CMS) reported that overall ACA plan selections fell approximately 5% in 2026 following the subsidy expiration, with the share of enrollees in bronze-tier plans rising from 30% to 40% nationally as consumers shifted to cheaper, higher-deductible coverage. The market is now smaller, more expensive per member, and weighted toward plans that carry higher cost-sharing at the point of care.
Centene’s Medicare segment was the quarter’s clearest outperformer, with an HBR of 93.8%, down from 94.3% in Q3 2025. Medicare PDP membership grew to 8.9 million from eight million a year earlier, with the segment producing meaningful margin improvement. The company has been rebuilding from a difficult 2025, when a $6.7 billion goodwill impairment booked in the third quarter of 2025 drove a full-year GAAP diluted loss of $13.53 per share. The Medicare outperformance and PDP membership growth are the primary engine of the recovery.
For 2027, Centene has signaled it will simplify its Medicare Advantage footprint further, concentrating on dual-eligible members - those who qualify for both Medicare and Medicaid - where it views its Medicaid operational expertise as a competitive differentiator. Dual-eligible members already represent approximately 40% of its Medicare Advantage portfolio. That strategic narrowing carries implications for carrier access in Medicare Advantage markets where Centene currently participates more broadly.
The Medicaid segment, Centene’s largest by membership at 11.9 million, posted an HBR of 93.6% in Q3, essentially flat with the prior year at 93.4%. Medicaid rate increases tied to medical cost trend have helped stabilize margins, though Medicaid work requirements legislated under last year’s budget law are set to take effect in January 2027.
Centene has the largest Medicaid managed care exposure of any US insurer. How it manages the anticipated membership reduction from those requirements will be one of the more closely watched developments in the government insurance market next year.
“Solid underlying fundamentals within our core businesses have powered a faster recovery to our earnings trajectory than previously anticipated,” said Sarah M. London, Centene’s chief executive officer.
